3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Promyelocytic, Acute
5
Thrombocytopenia
2
Pathologic Complete Response
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Primary Myelofibrosis
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Oligometastatic Disease
1
Oligodendroglioma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Leukemia, Myeloid, Acute
1
Leiomyosarcoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
HER2 Negative Breast Cancer
1
Glioma
1
Interventions
Specimen Handling
3
Biopsy
3
Azacitidine
2
venetoclax
1
veliparib
1
ruxolitinib
1
pevonedistat
1
peginterferon alfa-2b
1
onvansertib
1
fludarabine phosphate
1
axatilimab
1
Whole-Body Irradiation
1
Valganciclovir
1
Transplantation Conditioning
1
Topotecan
1
Therapeutics
1
Tacrolimus
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Hyperbaric Oxygenation
1
High-Energy Shock Waves
1
Geriatric Assessment
1
Ganciclovir
1
Foscarnet
1
Flow Cytometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Tretinoin
×
1 year
×
Clear all
No trials found.